The Norwegian Inflammation Network (NORIN) in partnership with Oslo Cancer Cluster welcomes you to: “Unintended consequences: autoimmunity as an adverse effect of modern immunotherapy in cancer”. This meeting is sponsored by Abbvie, Janssen and Takeda. Program 15:00 Welcome 15:10-15:50 Asim Amin, Levine Cancer Institute, Carolinas Medical Center “Immunotherapy for Cancer: A double-edged sword” 15:50-16:05 Ansgar Heck, […]
Contact us >
Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines.
We are a national non-profit member organization with about 90 members. Our members are Norwegian and international companies, research and financial institutions, university hospitals and organizations – all working in the cancer field.